The ESC Congress took place in Amsterdam from 25th to 28th August 2023. Several CORE-MD partners presented their results during the various sessions of this major Scientific Congress.
𝗣𝗿𝗼𝗳 𝗔𝗹𝗮𝗻 𝗙𝗿𝗮𝘀𝗲𝗿, chairperson of the ESC TV 📺 Special Session “Clinical evidence for high-risk devices“, engaged in an insightful discussion with Stephen Windecker and Perla Marang-van de Mheen who shared the early results of the tasks they lead within which we have been reviewing the available clinical evidence on high-risk #medicaldevices in the fields of #cardiology, #orthopaedics and #diabetes as well as the quality and utility of registries for MD safety and performance assessment.
Other presentations were made by CORE-MD partners as outline below.
📌 𝗔 𝗰𝗿𝗶𝘁𝗶𝗰𝗮𝗹 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝗵𝗶𝗴𝗵-𝗿𝗶𝘀𝗸 𝗶𝗺𝗽𝗹𝗮𝗻𝘁𝗮𝗯𝗹𝗲 𝗱𝗲𝘃𝗶𝗰𝗲𝘀 𝗶𝗻 𝗰𝗮𝗿𝗱𝗶𝗼𝗹𝗼𝗴𝘆: 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗳𝗿𝗼𝗺 𝗖𝗢𝗥𝗘-𝗠𝗗, https://lnkd.in/dgXxWRMX, 28 August, chaired by Robert Byrne and Perla Marang-van de Mheen, with Georgios Siontis, Stephen Windecker, Laurna McGovern and Lotje Hoogervorst
📌 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗲𝘃𝗶𝗱𝗲𝗻𝗰𝗲 𝗳𝗼𝗿 𝗵𝗶𝗴𝗵-𝗿𝗶𝘀𝗸 𝗰𝗮𝗿𝗱𝗶𝗼𝘃𝗮𝘀𝗰𝘂𝗹𝗮𝗿 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲𝘀: 𝗔 𝘀𝘆𝘀𝘁𝗲𝗺𝗮𝘁𝗶𝗰 𝗲𝘃𝗮𝗹𝘂𝗮𝘁𝗶𝗼𝗻 𝗼𝗳 𝘁𝗵𝗲 𝗖𝗢𝗥𝗘-𝗠𝗗 𝗖𝗼𝗻𝘀𝗼𝗿𝘁𝗶𝘂𝗺, https://lnkd.in/dRtvwwHK, Session: New trials miscellany, Stephen Windecker, 28 August,
📌 𝗗𝗲𝘃𝗲𝗹𝗼𝗽𝗺𝗲𝗻𝘁 𝗼𝗳 𝗮𝗻 𝗔𝗜-𝗯𝗮𝘀𝗲𝗱 𝗜𝗧 𝘁𝗼𝗼𝗹 𝘁𝗼 𝘀𝘂𝗽𝗽𝗼𝗿𝘁 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗱𝗲𝘃𝗶𝗰𝗲 𝗻𝗼𝗺𝗲𝗻𝗰𝗹𝗮𝘁𝘂𝗿𝗲 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝗶𝘇𝗮𝘁𝗶𝗼𝗻 𝗳𝗼𝗿 𝗽𝗼𝘀𝘁-𝗺𝗮𝗿𝗸𝗲𝘁 𝘀𝘂𝗿𝘃𝗲𝗶𝗹𝗹𝗮𝗻𝗰𝗲 𝗯𝘆 𝗮𝘂𝘁𝗼𝗺𝗮𝘁𝗲𝗱 𝗺𝗮𝗽𝗽𝗶𝗻𝗴 𝗳𝗿𝗼𝗺 𝗚𝗠𝗗𝗡 𝘁𝗼 𝗘𝗠𝗗𝗡 𝘀𝘁𝗮𝗻𝗱𝗮𝗿𝗱𝘀, https://lnkd.in/dSW_82CE, Session: Innovations in public health and health economics, Enrico Gianluca Caiani, 28 August
